Inventor
STEFFENSEN SOREN
BE22 patents
⚠️ This page may combine multiple inventors who share the name “STEFFENSEN SOREN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABLYNX NV
13 patentsUS10858418B2Dec 8, 2020
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
ABLYNX NV18 citations93
US9683045B2Jun 20, 2017
Biological materials related to c-Met
ABLYNX NV17 citations92
US11192938B2Dec 7, 2021
Serum albumin binding proteins containing immunoglobulin single variable domains
ABLYNX NV5 citations83
US11192937B2Dec 7, 2021
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
ABLYNX NV5 citations83
US9346884B2May 24, 2016
Biological materials related to c-Met
ABLYNX NV15 citations83
US11414481B2Aug 16, 2022
Serum albumin binders
ABLYNX NV6 citations82
US11414480B2Aug 16, 2022
Serum albumin binding immunoglobulin single variable domains
ABLYNX NV6 citations78
US12516105B2Jan 6, 2026
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
ABLYNX NV1 citations74
US12006352B2Jun 11, 2024
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
ABLYNX NV1 citations72
US11644471B2May 9, 2023
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
ABLYNX NV2 citations72
US11603401B2Mar 14, 2023
Aggrecan binding immunoglobulins
ABLYNX NV2 citations68
US11466089B2Oct 11, 2022
Chemokine receptor binding polypeptides
ABLYNX NV0 citations61
US11897944B2Feb 13, 2024
Immunoglobulin single variable domain (ISVD) capable of binding to serum albumin
ABLYNX NV1 citations59